HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
IL-17, a major inflammatory cytokine plays a critical role in the pathogenesis of many autoimmune inflammatory diseases. In this study, we report a new function of RNA-binding protein HuR in IL-17-induced Act1-mediated chemokine mRNA stabilization. HuR deficiency markedly reduced IL-17-induced chemokine expression due to increased mRNA decay. Act1-mediated HuR polyubiquitination was required for the binding of HuR to CXCL1 mRNA, leading to mRNA stabilization. Although IL-17 induced the coshift of Act1 and HuR to the polysomal fractions in a sucrose gradient, HuR deficiency reduced the ratio of translation-active/translation-inactive IL-17-induced chemokine mRNAs. Furthermore, HuR deletion in distal lung epithelium attenuated IL-17-induced neutrophilia. In summary, HuR functions to couple receptor-proximal signaling to posttranscriptional machinery, contributing to IL-17-induced inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rather, IL-17 employs the RBPs HuR and Arid5a to prolong the half-life of certain target transcripts.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Herjan et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“HuR, in cooperation with Act1, promotes Cxcl1 stability in part by sterically displacing the destabilizing RBP ASF:SF2 on the 3’ UTR”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Herjan et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
Ye, P., Rodriguez, F. H., Kanaly, S., Stocking, K. L., Schurr, J., Schwarzenberger, P., Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.4.519 · Cited by 1,521
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517
Decapping and Decay of Messenger RNA Occur in Cytoplasmic Processing Bodies
Sheth, U., & Parker, R. (2003) · Science · doi:10.1126/science.1082320 · Cited by 1,365
Brennan, C. M., & Steitz*, J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000854 · Cited by 1,095 · cited 1×
“HuR, a member of the embryonic lethal abnormal vision family of RNAbinding proteins, contains three classical RNA-binding domains (RNA-recognition motifs) implicated in ARE recognition (43).”
BackgroundNakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“pulmonary inflammation and airway hyperresponsiveness (13, 14).”
Cited by
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“These RBPs bind 3’ UTR motifs and counteracting the activity of de-stabilizing ribonucleases (see below) (Amatya et al., 2018; Herjan et al., 2013; Puel and Casanova, 2018).”
BackgroundInfluentialIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“Since HuR and SF2 recognize similar sequences within the 3′UTR, HuR sterically competes with SF2 and prevents SF2mediated RNA decay [90] (Figure 3).”
BackgroundChung, L., Thiele Orberg, E., Geis, A. L., Chan, J. L., Fu, K., DeStefano Shields, C. E., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.007 · Cited by 644
“We did not find significant ETBF-mediated changes in expression of either Tnfaip3 that encodes the deubiquitinase, A20, a negative regulator of IL-17R (Garg et al., 2013) or Elavl1 encoding the protein Hur (Herjan et al., 2013) that is involved in in Act1-mediated stabilization of Cxcl mRNA upon IL-17 signaling (Fig.”
InfluentialIL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“In addition to theAct1/TRAF2/TRAF5/SF2(ASF) complex, we recently found that an SF2(ASF)-independent complex composed of Act1/TRAF2/TRAF5 and HuR, an RNAbinding protein, can mediate IL-17A-dependent mRNA stabilization[56].”
BackgroundSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
“By recruiting TRAF2/5, Act-1 favors the sequestration of RNA decay factor, such as SF2 (57), as well as the activation of RNA-binding proteins as, such HuR (58), which results in increased mRNA stability of target genes.”
BackgroundThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“70,71 Skin in fl ammation .”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
Self-citationZhong, Z., Su, G., Kijlstra, A., & Yang, P. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100866 · Cited by 247
IL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
“Important for mRNA stabilization is the formation of the TRAF2/TRAF5 complex and recruitment of HuR and ASF/SF2, which stabilize mRNA transcript targets (Datta et al., 2010, Sun et al., 2011, Herjan et al., 2013) (Figure 1).”
Korbecki, J., Barczak, K., Gutowska, I., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020792 · Cited by 173
“Act1 causes the phosphorylation of SF2/ASF via the inhibitor of NF-κB kinase ε (IKKε) [43] and forms the Act1-TRAF2-TRAF5-SF2/ASF complex [118,119].”
BackgroundGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“In turn, phosphorylated Act1 binds TRAF2 and TRAF5, which sequester the RNA binding protein SF2 to allow binding of the mRNA-stabilizing factor HuR (Bulek et al., 2011; Herjan et al., 2013; Sun et al., 2011).”
Chen, K., Eddens, T. J., Trevejo-Nuñez, G., Way, E. E., Elsegeiny, W. A. W., Ricks, D. M., Garg, A. V., Erb, C., Bo, M., Wang, T., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.003 · Cited by 145
Wong, H., & Hoeffer, C. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.010 · Cited by 129
“This complex can stabilize CXCL1 or CXCL5 mRNAs by preventing ASF cleavage of the mRNA and enhancing expression of the encoded protein (Herjan et al., 2013).”
BackgroundThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
Self-citationHerjan, T., Hong, L., Bubenik, J., Bulek, K., Qian, W., Liu, C., Li, X., Chen, X., Yang, H., Ouyang, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0071-9 · Cited by 121
“Although ARE binding protein SF2 (Splicing factor 2) and HuR (human antigen R) were previously implicated in IL-17-induced mRNA stabilization, the recruitment of SF2 and HuR cannot explain the receptor-specific mRNA stabilization of select inflammatory genes 19, 20 .”
Self-citationJhingran, A., Kasahara, S., Shepardson, K. M., Junecko, B. A. F., Heung, L. J., Kumasaka, D. K., Knoblaugh, S. E., Lin, X., Kazmierczak, B. I., Reinhart, T. A., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004589 · Cited by 108
“Because CXCL1 mRNA stability is regulated in part by inflammatory stimuli [36], we carried out in situmRNA hybridization on lung sections of 3 × 10(7) Af293 or PBS administered MyD88 and WTmice, with gene-specific riboprobes for cxcl1 and cxcl2.”
MethodThe metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
TRAF Regulation of IL-17 Cytokine Signaling
Swaidani, S., Liu, C., Zhao, J., Bulek, K., & Li, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01293 · Cited by 110
“Evidently, through Act1-TRAF2/5 dependent mechanism, IL-17A signaling can also activate the mRNA stabilizing factor human antigen R (HuR)/ELAVL1 (51).”
BackgroundSelf-citationThe Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis
Paquissi, F. C., & Abensur, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.654912 · Cited by 101
Shenoy, A. T., Wasserman, G. A., Arafa, E. I., Wooten, A. K., Smith, N. M. S., Martin, I. M. C., Jones, M. R., Quinton, L. J., & Mizgerd, J. P. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0229-2 · Cited by 98
Korbecki, J., Gąssowska-Dobrowolska, M., Wójcik, J., Szatkowska, I., Barczak, K., Chlubek, M., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084205 · Cited by 99
“There is also an increase in IL-17 levels [211], a cytokine that increases CXCL1 expression [32,33].”
BackgroundKorbecki, J., Maruszewska, A., Bosiacki, M., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010205 · Cited by 98
Bechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
“Act1, in conjunction with TRAF2, has the capacity to bind to target mRNAs and control their stability and direct translation (24, 25).”
BackgroundKe, Y., Han, Y., Guo, X., Wen, J., Wang, K., Jiang, X. Y., Tian, X., Ba, X., Boldogh, I. R., & Zeng, X. (2017) · Nature Communications · doi:10.1038/ncomms14632 · Cited by 99
DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions
(2018) · doi:10.1016/j.celrep.2018.10.012 · Cited by 83
Control of RNA Stability in Immunity
Akira, S., & Maeda, K. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-075147 · Cited by 92
Interleukin‐17 and ischaemic stroke
Zhang, Q., Liao, Y., Liu, Z., Dai, Y., Li, Y., Li, Y., & Tang, Y. (2020) · Immunology · doi:10.1111/imm.13265 · Cited by 87
The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases
Țiburcă, L., Bembea, M., Zaha, D. C., Jurcă, A. D., Vesa, C. M., Rațiu, I. A., & Jurca, C. M. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44050127 · Cited by 85
“TRAF2/5, on he oth r hand, is involved in the m intenance of stability of the RNA molecule by sequestering the disintegration factor and by activating the RNA bi ding proteins [30,31].”
BackgroundProtective role of Th17 cells in pulmonary infection
Rathore, J. S., & Wang, Y. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.021 · Cited by 85
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
“Rather, RBPs such as HuR, DDX3X, and Act1 serve to stabilize IL-17– dependent transcripts in a pathway initiated by TRAF2 and TRAF5 (19, 20, 28).”
BackgroundInfluentialTh17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response
Tanaka, H., Arima, Y., Kamimura, D., Tanaka, Y., Takahashi, N., Uehata, T., Maeda, K., Satoh, T., Murakami, M., & Akira, S. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181078 · Cited by 79
Targeting the Multifaceted HuR Protein, Benefits and Caveats
Zucal, C., D’Agostino, V., Loffredo, R., Mantelli, B., Thongon, N., Lal, P., Latorre, E., & Provenzani, A. (2015) · Current Drug Targets · doi:10.2174/1389450116666150223163632 · Cited by 71
“A more straightforward role of HuR in the modulation of IL-17 has been reported: HuR deletion in distal lung epithelium attenuated IL-17–induced neutrophilia and pulmonary inflammation in vivo [104].”
BackgroundBeiter, T., Hoene, M., Prenzler, F., Mooren, F. C., Steinacker, J. M., Weigert, C., Niess, A. M., & Munz, B. (2026) · Exercise immunology review · doi:10.22029/eir.2015.1695 · Cited by 65
Role of epithelial chemokines in the pathogenesis of airway inflammation in asthma (Review)
Liu, C., Zhang, X., Xiang, Y., Qu, X., Liu, H., Liu, C. X., Tan, M., Jiang, J., & Qin, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8739 · Cited by 73
“It has been demonstrated that IL-17 promotes the expression of CXCL1 and CXCL5 in bronchial epithelial cells and that IL-17 potentially promotes CXCL1 expression mainly through the extracellular regulated protein kinases (ERK) or MAPK pathway (33).”
BackgroundSelf-citationIL-17–induced HIF1α drives resistance to anti–PD-L1 via fibroblast-mediated immune exclusion
Chen, X., Zhao, J., Herjan, T., Hong, L., Liao, Y., Liu, C., Vasu, K., Wang, H., Thompson, A., Fox, P. L., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20210693 · Cited by 53
Self-citationCRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype
Lal, S., Cheung, E. C., Zarei, M., Preet, R., Chand, S. N., Mambelli-Lisboa, N. C., Romeo, C., Stout, M. C., Londin, E. R., Goetz, A. B., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0361 · Cited by 56
“Interestingly, mice with conditional HuR deletion in a cell/tissue-specific manner are viable as observed in the GI tract (41,42), lung epithelium (43,44), brain (45), T-cells (46), and macrophages (47), and suggested that deletion of HuR in GI cancer cells would be feasible.”
BackgroundTherapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis
Tseng, J., Chang, Y.-C., Huang, C., Hsu, L.-C., & Chuang, T. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071064 · Cited by 56
Deng, Q., Chen, H., Liu, Y., Xiao, F., Guo, L., Liu, D., Cheng, X., Zhao, M., Wang, X., Xie, S., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.017 · Cited by 50
Post-transcriptional regulation of inflammation by RNA-binding proteins via cis-elements of mRNAs
Uchida, Y., Chiba, T., Kurimoto, R., & Asahara, H. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz067 · Cited by 55
Mechanisms of Corticosteroid Resistance in Type 17 Asthma
Hong, L., Herjan, T., Bulek, K., Xiao, J., COMHAIR, S. A. A., ERZURUM, S. C., Li, X., & Liu, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200288 · Cited by 47
Self-citationPromotion of lung tumor growth by interleukin-17
Xu, B., Guenther, J. F., Pociask, D. A., Wang, Y., Kolls, J. K., You, Z., Chandrasekar, B., Shan, B., Sullivan, D. E., & Morris, G. F. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00125.2014 · Cited by 47
“Positive control experiments replicated previous findings (19), demonstrating an IL-17-dependent association between SRSF1 and CXCL-2 mRNA (Fig.”
MethodResultInterleukin-17A in lipid metabolism and atherosclerosis
Yu, X., Jiang, N., Zheng, X., Cayabyab, F. S., Tang, Z.-B., & Tang, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.012 · Cited by 42
Regulation of AU-Rich Element RNA Binding Proteins by Phosphorylation and the Prolyl Isomerase Pin1
Shen, Z.-J., & Malter, J. S. (2015) · Biomolecules · doi:10.3390/biom5020412 · Cited by 42
Nlrp12 Mediates Adverse Neutrophil Recruitment during Influenza Virus Infection
Hornick, E. E., Banoth, B., Miller, A. M., Zacharias, Z. R., Jain, N., Wilson, M. E., Gibson-Corley, K. N., Legge, K. L., Bishop, G. A., Sutterwala, F. S., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700999 · Cited by 44
“Scale bars and original magnification: left, 500 mm (32); middle, 100 mm (310); right, 20 mm (350).”
BackgroundInfluentialKorbecki, J., Szatkowska, I., Kupnicka, P., Żwierełło, W., Barczak, K., Poziomkowska‐Gęsicka, I., Wójcik, J., Chlubek, D., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137151 · Cited by 43
“In particular, CagA decreases the expression of IL-17 receptor B (IL-17RB) in gastric mucosa [60], a receptor for IL-17 that increases the stability of the CXCL1 transcript [61,62].”
BackgroundIRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs
Zhou, H., Bulek, K., Li, X., Herjan, T., Yu, M., Qian, W., Wang, H., Zhou, G., Chen, X., Yang, H., et al. (2017) · eLife · doi:10.7554/elife.29630 · Cited by 38
“The RIP assay was performed following the protocols as previous described (Herjan et al., 2013; Keene et al., 2006).”
MethodSelf-citationHuang, G., Wang, Y., Vogel, P., & Chi, H. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2147 · Cited by 37
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“Interleukin-17 also induces the interactions of Act1 and IKKi and TANK-Binding Kinase 1 (TBK1), which translocate to nucleus and phosphorylate splicing factor(SF)2 and diminishes SF2 mediated mRNA decay [83,84].”
BackgroundSystematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“…of mRNA transcripts via ACT1 and TRAF2/5, which regulate mRNA stability either directly, or by modulating the activity of mRNA binding proteins ARID5A and HuR, splicing factor SF2, and endoribonuclease Regnase-1 (Sun et al , 2011; Herjan et al , 2013, 2018; Somma et al , 2015; Amatya et al , 2018).”
Assoni, G., Pietra, V. L., Digilio, R., Ciani, C., Licata, N. V., Micaelli, M., Facen, E., Tomaszewska, W., Cerofolini, L., Pérez‐Ràfols, A., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114088 · Cited by 35
IL‐17 in intervertebral disc degeneration: Mechanistic insights and therapeutic implications
Tan, J., Li, Z., Liu, L., Liu, H., & Xue, J. (2022) · Cell Biology International · doi:10.1002/cbin.11767 · Cited by 34
“Following polyubiquitination by Act1, HuR binds to CXC chemokine ligand 1 (CXCL1) mRNA and consequently increases its | 537 stability (Herjan et al., 2013).”
BackgroundPost‐transcriptional control of immune responses and its potential application
Yoshinaga, M., & Takeuchi, O. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1063 · Cited by 33
“polyubiquitination of HuR, leading to the stabilisation of Cxcl1 mRNA.(39) Thus, Act1 may regulate the stability of mRNA via multiple mechanisms.”
BackgroundInterleukin-17: Functional and Structural Features, Application as a Therapeutic Target
Kostareva, O. S., Gabdulkhakov, A. G., Kolyadenko, I., Garber, M., & Tishchenko, S. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919140116 · Cited by 36
IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives
Witowski, J., Kamhieh‐Milz, J., Kawka, E., Catar, R. A., & Jörres, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01694 · Cited by 28
The Differential Regulation of Human ACT1 Isoforms by Hsp90 in IL-17 Signaling
Wu, L., Wang, C., Boisson, B., Misra, S., Rayman, P. A., Finke, J. H., Puel, A., Casanova, J., & Li, X. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400715 · Cited by 29
Self-citationKe, Y., Lv, X., Fu, X., Zhang, J., Bohio, A. A., Zeng, X., Hao, W., Wang, R., Boldogh, I. R., & Ba, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03618-4 · Cited by 28
Jiang, Y., Tian, M., Lin, W., Wang, X., & Wang, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00921 · Cited by 25
“In addition to the activation of TRAF6, Act1, which is phosphorylated by IKKi, also recruits TRAF2 and TRAF5 to prolong the half-life of IL-17-stimulated mRNA (13, 14).”
BackgroundPost-transcriptional checkpoints in autoimmunity
Bechara, R., Vagner, S., & Mariette, X. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00980-y · Cited by 25
Epigenetic Regulation of IL-17-Induced Chemokines in Lung Epithelial Cells
Luo, J., An, X., Yao, Y., Erb, C., Ferguson, A. A., Kolls, J. K., Fan, S., & Chen, K. (2019) · Mediators of Inflammation · doi:10.1155/2019/9050965 · Cited by 26
Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes
Korbecki, J., Bosiacki, M., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713287 · Cited by 24
Neuron-Specific HuR-Deficient Mice Spontaneously Develop Motor Neuron Disease
Sun, K. Y., Li, X., Chen, X., Bai, Y., Zhou, G., Kokiko‐Cochran, O. N., Lamb, B. T., Hamilton, T. A., Lin, C., Lee, Y., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701501 · Cited by 22
“These mice were crossed to HuR flox/flox mice (described previously (7)) to generate conditional neuron-specific HuR KO mice (Thy1Cre-ERT2-EYFPHuRf/f) and control mice (Thy1Cre-ERT2-EYFPHuRf/f).”
Self-citationThe RNA-Binding Protein IMP2 Drives a Stromal-Th17 Cell Circuit in Autoimmune Neuroinflammation
Bechara, R., Amatya, N., Majumder, S., Zhou, C., Li, Y., Liu, Q., McGeachy, M. J., & Gaffen, S. L. (2022) · JCI Insight · doi:10.1172/jci.insight.152766 · Cited by 18
“While IMP2 functions primarily in nonhematopoietic cells by virtue of selective expression in these cell types (18), HuR is more widely expressed and has more profound impacts on Th17 cells in addition to acting on IL-17–responsive cells (30, 36, 37).”
BackgroundHong, J.-H., & Lee, Y. (2022) · Life · doi:10.3390/life12060857 · Cited by 18
“Its cytokine, IL-17, promotes the expression of CXCL1 and CXCL5 in bronchial epithelial cells, which leads to neutrophil production and recruitment [59].”
BackgroundKim, H. J., Dinh, D. T. T., Yang, J., Herath, K. H. I. N. M., Seo, S. H., Son, Y., Kang, I., & Jee, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109504 · Cited by 18
Ünver, N. (2021) · Medical Oncology · doi:10.1007/s12032-021-01517-7 · Cited by 16
“IL-17 stimulates CXCL1 and CXCL5 expression in bronchial epithelial cells and IL-17 potentially promotes CXCL1 expression primarily via the ERK or MAPK pathway [28].”
BackgroundThe RNA binding protein Arid5a drives IL-17–dependent autoantibody-induced glomerulonephritis
Li, Y., Vyas, S., Mehta, I. D., Asada, N., Dey, I., Taylor, T. C., Bechara, R., Amatya, N., Aggor, F. E. Y., Coleman, B. M., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240656 · Cited by 15
“It is not surprising that Arid5a is multifunctional, as many RBPs (HuR and Act1, for example, in the IL-17 pathway) have both RNA stabilization and translation capabilities (Herjan et al., 2013, 2018; Nyati et al., 2020; Sun et al., 2011).”
Liang, Q., He, L., Wang, J., Tang, D., Wu, C., & Peng, W. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116598 · Cited by 17
Zhu, J. J., Stenfeldt, C., Bishop, E. A., Canter, J. A., Eschbaumer, M., Rodríguez, L. L., & Arzt, J. (2020) · Frontiers in Veterinary Science · doi:10.3389/fvets.2020.00340 · Cited by 14
Self-citationArid5a Mediates an IL-17–Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense
Taylor, T. C., Li, Y., Li, D., Majumder, S., McGeachy, M. J., Biswas, P. S., Gingras, S., & Gaffen, S. L. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200132 · Cited by 14
T cell transgressions: Tales of T cell form and function in diverse disease states
Harris, K. M., Clements, M. A., Kwilasz, A. J., & Watkins, L. R. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1921764 · Cited by 12
“HuR increases the half-life of target mRNAs by sterically competing with the mRNA destabilizing factor ASF/SF2 [147,148].”
BackgroundMolecular mechanisms and clinical impact of biologic therapies in severe asthma
Tashiro, H., Kuwahara, Y., Kurihara, Y., & Takahashi, K. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.11.015 · Cited by 12
Kidney-Specific Interleukin-17 Responses During Infection and Injury
Peroumal, D., & Biswas, P. S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-052523-015141 · Cited by 12
Wang, K., Tong, H., Gao, Y., Xia, L., Xin, J., Li, X., Zeng, X., Boldogh, I. R., Ke, Y., & Ba, X. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200002 · Cited by 8
Self-citationLi, N., Lee, Y., Suh, J. H., Oh, J., Jin, S., Lee, D. H., & Chung, J. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166988 · Cited by 9
Autoimmune hepatitis: Towards a personalized treatment
Costaguta, A., Costaguta, G. A., & Álvarez, F. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i11.1225 · Cited by 10
Herjan, T., Xiao, J., & Kolanek, M. D. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0171 · Cited by 9
Self-citationRegulation of Interleukin-17 Production
Dong, W., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_7 · Cited by 7
C/EBPδ Mediates Immunity to Renal Autoinflammatory Disorders in a Stage-specific Manner
Dey, I., Li, Y., Taylor, T. C., Peroumal, D., Asada, N., Panzer, U., Biswas, P. S., Sterneck, E., & Gaffen, S. L. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400124 · Cited by 6
Secklehner, J., Filippo, K. D., Mackey, J. B. G., Vuononvirta, J., Iraolagoitia, X. L. R., McFarlane, A. J., Neilson, M., Headley, M. B., Krummel, M. F., Guerra, N., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/680611 · Cited by 6
“4D, E; Table S3) in NK cell-depleted compared IgG treated mice and levels of CXCL1 and CXCL2 were comparable (Fig.”
BackgroundInfluentialAct1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
“…and Regnase-1 [Iwasaki et al., 2011; Mino et al., 2015]) and mediate the sequential deadenylation, decapping, and ultimately exonucleolytic degradation of the RNA (Bulek et al., 2011; Herjan et al., 2013; Schoenberg and Maquat, 2012; Somma et al., 2015; Stumpo et al., 2010; Sun et al., 2011).”
Self-citationRole of Inflammatory Cytokines in the Initiation and Progression of Pancreatic Cancer
Santharam, M. A., & Dhandapani, V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_8 · Cited by 3
Yang, F., Li, M., Zuo, Y., Zhang, L., Wu, J., Liu, Z., & Wang, H. (2025) · Antioxidants · doi:10.3390/antiox14101184 · Cited by 2
“Emerging evidence indicates RNA-binding proteins (RBPs), such as HuR, act as critical modulators of IL-17-related transcripts by modulating their stability and translation, thereby fine-tuning inflammatory responses [13,14].”
Interleukins in community-acquired pneumonia: from biomarkers to precision medicine
Zhang, X., Zhang, T., Geng, R., Wei, L., Liu, H., & Shi, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1774731 · Cited by 1
Vunakizumab for IL-17A–Mediated Diseases: A Review in Psoriasis and Spondyloarthritis
Yan, H., Chen, Y., Song, Y., Yan, M., & Yan, K. (2026) · Biologics · doi:10.2147/btt.s500475 · Cited by 1
Lai, Y., & Dong, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10014-1 · Cited by 1
FEEDBACK INHIBITION OF IL-17 RECEPTOR SIGNAL TRANSDUCTION
Garg, A. V. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
FUNCTIONAL REGULATION OF INTERLEUKIN-17 RECEPTOR SIGNALING
Cruz, J. A. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Genetic basis of chronic mucocutaneous candidiasis disease in humans
Lévy, R. (2017) · theses.fr (ABES) · doi:10.70675/fbe0154ez44e5z43ccza33azb697756b8b48
Gaffen, S. L., & Amatya, N. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732887195.793546043
The roles of MCPyV early region in IL-17A-mediated inflammation and autophagy
Miao, J. (2021) · theses.fr (ABES) · doi:10.70675/0ed263f9za522z491ezb888z3d6d2826cd2b
Lai, Y., & Dong, C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00090-9
Φαρμακογενετική ανάλυση του γονιδίου IL-17RA σε ασθενείς με ψωρίαση
Μούρτου, Κ. Ι. (2024) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.40808
Miralles, C. M., Manousakis, E., Moreta-Moraleda, C., Baccara, H., Mahon, L., Franquet, L. L., Albó, M. M. I., Pujolà, A. T., Ferrari, R., & Wright, R. H. G. (2026) · Research Square · doi:10.21203/rs.3.rs-9982165/v1
Targeting the IL-17A Cytokine Interface: Structural Insights and Small-Molecule Modulators
Kim, G. U., Lee, A., Lee, S., Jeon, B., Park, H., Kang, T., & Choo, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01296
Metadata
- Authors
- Herjan, T., Yao, P., Qian, W., Li, X., Liu, C., Bulek, K., Sun, D., Yang, W.-P., Zhu, J., He, A., Carman, J. A., Erzurum, S. C., Lipshitz, H. D., Fox, P. L., Hamilton, T. A., & Li, X.
- Affiliations
- Cleveland Clinic (US)
- Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation , Cleveland, OH 44195
- Bristol-Myers Squibb (United States) (US)
- University of Toronto (CA)
- Corresponding author
- Herjan, Tomasz
- Liu, Caini
- Bulek, Katarzyna
- Sun, Dongxu
- Li, Xiaoxia
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07
- Volume
- 191
- Issue
- 2
- Pages
- 640-649
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3722902
- OpenAlex
- W2147320595
- Cited by
- 95
- References
- 48
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 6 · 2023: 7 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 12 · 2018: 11 · 2017: 7 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 1
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1r01ns071996-01a1)
- National Heart, Lung, and Blood Institute (P01HL103453, U10HL109250)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, 1R01NS071996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- HuR, IL-17, Act1, CXCL1, CXCL5, mRNA stabilization, polyubiquitination, chemokine expression, mRNA degradation, polysome association, post-transcriptional regulation, neutrophilia, lung epithelium, inflammation
- MeSH terms
- Animals, Cell Line, HeLa Cells, Humans, Inflammation, Lung, Protein Binding, RNA, Messenger, Signal Transduction, Mice, Knockout, Interleukin-17, Respiratory Mucosa, RNA Stability, Adaptor Proteins, Signal Transducing, Mice, ELAV Proteins, Chemokine CXCL1, Chemokine CXCL5, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.